Search results for "rotary vane pump"

Catch Specac at Pittcon, booth 4141 to learn about all their latest innovations

QIAGEN And Inova Translational Medicine Institute Introduce New Database of Ethnically and Phenotypically Diverse Whole Genome Information

SARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

Read highlights from our webinar about a new balance system that can determine minimum weight and standard deviation without the need for weights

Read on to discover facts about your lab’s treasure trove – the -80⁰C freezer

New follow-up assay helps stratify patients with transforming HPV infections

Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.

Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.

New blood test provides a unique new framework for early detection of the most common cancers

With abundant data on plants, large animals and their activity, and carbon soil levels in the Amazon, Stanford research suggests that large animal diversity influences carbon stocks and contributes to climate change mitigation

SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

Chromatographic method development factors, parameters and strategies

A look at some of the available companion diagnostics for breast, lung and colorectal cancer

Chromatography experts share how the latest 2D-LC technology can benefit your pharmaceutical, food, or polymer analysis applications and more